Intensified perfusion bioprocesses enable high cell density cultures with higher volumetric productivity and are a promising alternative to the fed-batch technology most commonly used in current biopharmaceutical production processes. Some of the key challenges when working with extremely high cell density cultures are high oxygen demand, consequent generation of shear stress, and foam by spargers, resulting in technical difficulties to maintain the bioprocesses. Our study demonstrates the optimization of bioreactor parameters and culture conditions enable very high cell densities using perfusion systems for intensified processes. One of the parameter focused in our study is to improve bioreactor performance measuring dissolved oxygen (DO) ...
Intensified perfusion processes are a key component in Integrated Continuous Biomanufacturing that s...
The demand for commercially valuable biopharmaceuticals able to treat different immunopathological d...
Biopharmaceutical industry is facing numerous challenges. Increased cost pressure, changing markets,...
Single use technologies (SUT) have become embedded in the biopharmaceutical industry over the last 2...
Intensified perfusion is recognized as an attractive technology for the production of biopharmaceuti...
Intensified upstream perfusion processes with cell densities well above 50x106vc/mL are being applie...
Continuous manufacturing has been investigated in both academia and industry as an alternative to ba...
Improvements in single-use systems have allowed implementation of high-density cultures in emerging ...
The continuous production of biopharmaceuticals combines several advantages: the use of smaller equi...
Peak cell densities in fed-batch cultures of mammalian cells can be limited by the depletion of nutr...
As part of efforts to develop a continuous processing platform for biologics manufacturing using sin...
The demand for commercially valuable biopharmaceuticals able to treat different immunopathological d...
The demand for commercially valuable biopharmaceuticals able to treat different immunopathological d...
As part of efforts to develop a continuous processing platform for biologics manufacturing using a s...
Recent advances in process intensification of perfusion cell culture have diverged into two general ...
Intensified perfusion processes are a key component in Integrated Continuous Biomanufacturing that s...
The demand for commercially valuable biopharmaceuticals able to treat different immunopathological d...
Biopharmaceutical industry is facing numerous challenges. Increased cost pressure, changing markets,...
Single use technologies (SUT) have become embedded in the biopharmaceutical industry over the last 2...
Intensified perfusion is recognized as an attractive technology for the production of biopharmaceuti...
Intensified upstream perfusion processes with cell densities well above 50x106vc/mL are being applie...
Continuous manufacturing has been investigated in both academia and industry as an alternative to ba...
Improvements in single-use systems have allowed implementation of high-density cultures in emerging ...
The continuous production of biopharmaceuticals combines several advantages: the use of smaller equi...
Peak cell densities in fed-batch cultures of mammalian cells can be limited by the depletion of nutr...
As part of efforts to develop a continuous processing platform for biologics manufacturing using sin...
The demand for commercially valuable biopharmaceuticals able to treat different immunopathological d...
The demand for commercially valuable biopharmaceuticals able to treat different immunopathological d...
As part of efforts to develop a continuous processing platform for biologics manufacturing using a s...
Recent advances in process intensification of perfusion cell culture have diverged into two general ...
Intensified perfusion processes are a key component in Integrated Continuous Biomanufacturing that s...
The demand for commercially valuable biopharmaceuticals able to treat different immunopathological d...
Biopharmaceutical industry is facing numerous challenges. Increased cost pressure, changing markets,...